NCT02183233View on ClinicalTrials.gov

Efficacy and Safety of Eschscholtzia Californica in Treating Primary Insomnia

PHASE3TerminatedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

January 31, 1998

Primary Completion Date

June 30, 1998

Conditions
Sleep Initiation and Maintenance Disorders
Interventions
DRUG

Eschscholtzia Californica

DRUG

Eschscholtzia Californica Placebo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02183233 - Efficacy and Safety of Eschscholtzia Californica in Treating Primary Insomnia | Biotech Hunter | Biotech Hunter